ByKrypto TrendsApril 6, 2026 A Game-Changing Acquisition: Neurocrine Expands Into Metabolic Disorders Neurocrine’s $2.9 Billion Bet: A Strategic Move Into Rare Diseases In a major move that could reshape its… Business
